pentoxifylline has been researched along with Carcinoma, Squamous Cell in 12 studies
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The data indicate a beneficial therapeutic effect of pentoxifylline and vitamin E on radiation-induced fibrosis." | 8.79 | [The treatment of cutaneous radiation-induced fibrosis with pentoxifylline and vitamin E. An empirical report]. ( Gottlöber, P; Korting, HC; Krähn, G; Peter, RU; Stock, W, 1996) |
| "The influence of pentoxifylline on radiotoxicity was assessed by colony assay in TP53 wild-type Bell and mutant MeWo melanoma, and in TP53 wild-type 4197 and mutant 4451 squamous cell carcinoma (SCC) cell lines." | 7.70 | The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline. ( Binder, A; Böhm, L; Theron, T; Verheye-Dua, F, 2000) |
| "Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment." | 5.43 | Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases. ( Bohn, JC; Sassi, LM; Schussel, JL; Stramandinoli-Zanicotti, RT, 2016) |
| "The data indicate a beneficial therapeutic effect of pentoxifylline and vitamin E on radiation-induced fibrosis." | 4.79 | [The treatment of cutaneous radiation-induced fibrosis with pentoxifylline and vitamin E. An empirical report]. ( Gottlöber, P; Korting, HC; Krähn, G; Peter, RU; Stock, W, 1996) |
| "This study is a retrospective review of treatment outcomes of osteoradionecrosis (ORN) of the mandible with specific reference to the evolving role of medical management with pentoxifylline, tocopherol, and doxycycline." | 3.80 | Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit. ( D'Souza, J; Lowe, D; Rogers, SN, 2014) |
| "The influence of pentoxifylline on radiotoxicity was assessed by colony assay in TP53 wild-type Bell and mutant MeWo melanoma, and in TP53 wild-type 4197 and mutant 4451 squamous cell carcinoma (SCC) cell lines." | 3.70 | The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline. ( Binder, A; Böhm, L; Theron, T; Verheye-Dua, F, 2000) |
| "The pentoxifylline was continued between chemotherapy cycles." | 2.67 | Cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of squamous cell carcinoma of the head and neck. ( Cripps, MC; Fingert, H; Gerin-Lajoie, J; Laframboise, G; Lamothe, A; Stewart, DJ, 1993) |
| "Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment." | 1.43 | Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases. ( Bohn, JC; Sassi, LM; Schussel, JL; Stramandinoli-Zanicotti, RT, 2016) |
| "Three squamous cell carcinoma cell lines, FaDu, RPMI 2650 and SCC-61, with differences in genomic imbalance and intrinsic radiosensitivity, were irradiated with 140 cGy/min (HDRI) and 0." | 1.33 | The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation. ( Danielsson, A; Delle, U; Helou, K; Karlsson, E; Mercke, C, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Souza, J | 1 |
| Lowe, D | 1 |
| Rogers, SN | 1 |
| Bohn, JC | 1 |
| Schussel, JL | 1 |
| Stramandinoli-Zanicotti, RT | 1 |
| Sassi, LM | 1 |
| Wheeler, DL | 1 |
| Ness, KJ | 1 |
| Oberley, TD | 1 |
| Verma, AK | 1 |
| Aygenc, E | 1 |
| Celikkanat, S | 1 |
| Kaymakci, M | 1 |
| Aksaray, F | 1 |
| Ozdem, C | 1 |
| Danielsson, A | 1 |
| Karlsson, E | 1 |
| Delle, U | 1 |
| Helou, K | 1 |
| Mercke, C | 1 |
| Hanly, AM | 1 |
| Hayanga, A | 1 |
| Winter, DC | 1 |
| Bouchier-Hayes, DJ | 1 |
| Amano, M | 1 |
| Monzen, H | 1 |
| Suzuki, M | 1 |
| Terai, K | 1 |
| Andoh, S | 1 |
| Tsumuraya, A | 1 |
| Hasegawa, T | 1 |
| Stewart, DJ | 1 |
| Cripps, MC | 1 |
| Fingert, H | 1 |
| Lamothe, A | 1 |
| Laframboise, G | 1 |
| Gerin-Lajoie, J | 1 |
| Gottlöber, P | 1 |
| Krähn, G | 1 |
| Korting, HC | 1 |
| Stock, W | 1 |
| Peter, RU | 1 |
| Theron, T | 1 |
| Binder, A | 1 |
| Verheye-Dua, F | 1 |
| Böhm, L | 1 |
| Mannel, RS | 1 |
| Blessing, JA | 1 |
| Boike, G | 1 |
| Binder, AB | 1 |
| Serafin, AM | 1 |
| Bohm, LJ | 1 |
2 reviews available for pentoxifylline and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Thrombomodulin: tumour biology and prognostic implications.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Down-Regulation; Gene Expression Regulatio | 2005 |
[The treatment of cutaneous radiation-induced fibrosis with pentoxifylline and vitamin E. An empirical report].
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Therapy, Combination; Fe | 1996 |
3 trials available for pentoxifylline and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Prophylactic effect of pentoxifylline on radiotherapy complications: a clinical study.
Topics: Aged; Carcinoma, Squamous Cell; Chemoprevention; Head and Neck Neoplasms; Humans; Male; Middle Aged; | 2004 |
Cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cy | 1993 |
Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2000 |
7 other studies available for pentoxifylline and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Changing trends and the role of medical management on the outcome of patients treated for osteoradionecrosis of the mandible: experience from a regional head and neck unit.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antioxidants; Carcinoma, Squamous Cell; Debridement; | 2014 |
Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases.
Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Thera | 2016 |
Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Female; Keratinocytes; Male; Mice; Mice, Inbred C57B | 2003 |
The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.
Topics: Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; DNA Repair; Dose-Response Relationship, | 2005 |
Increase in tumor oxygenation and potentiation of radiation effects using pentoxifylline, vinpocetine and ticlopidine hydrochloride.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Mice; Mice, Inbred C3H; Oxi | 2005 |
The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline.
Topics: Apoptosis; Carcinoma, Squamous Cell; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Radiat | 2000 |
Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2000 |